|MDACC Study No:||2010-0035 (clinicaltrials.gov NCT No: NCT01321008)|
|Title:||Radiation Therapy Followed by Chemotherapy for Newly Diagnosed Patients with Stage I/II Nasal NK Cell Lymphoma |
|Principal Investigator:||Bouthaina Dabaja|
|Treatment Agent:||Adriamycin; Cyclophosphamide; Prednisone; Radiation; Vincristine|
|Study Description:||The goal of this clinical research study is to learn if radiation therapy and |
chemotherapy can help control stage 1 and/or 2 NK cell lymphoma. The safety of
radiation and chemotherapy will also be studied.